Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Latest reported RYTM revenue for 2026-06-30 was $131.4M. Net income was -$104.9M. RYTM currently screens at market cap $6.49B.
Use this RYTM page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the RYTM quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the RYTM SEC filings page. Lician reads the product cache first so this HTML stays unique to Rhythm Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full RYTM income, balance, and cash tables.